News Archive
Dr. Rosenberg on the challenges facing the Pharmaceutical Industry
Michael Rosenberg, CEO of Health Decisions is a recognized authority in the world of Clinical Trials (especially Adaptive Clinical Trials) as well as being a true entrepreneur...........
To read the entire interview please visit PharmaNation
Health Decisions at DIA 2008
Booth #1906
June 22-25
Boston Convention and Exhibition Center
Visit the official DIA Website.
Dr. Rosenberg to Chair and Speak at DIA 2008
Dr. Michael Rosenberg
President and CEO, will be speaking on
Adaptive Design in Clinical Research
June 23rd
10:30 AM – 12:00 PM
Session #107, Room 204AB
Join us to see the pragmatic aspects of running adaptive programs.
Adaptive Clinical Development: Strategic and Tactical Aspects
Dr. Michael Rosenberg to speak at the annual AAPS meeting
Dr. Rosenberg, MD, MPH will be speaking at the AAPS annual meeting on Adaptive Clinical Development: Strategic and Tactical Aspects on November 12th at 10am. The conference will take place November 11 – 15, 2007 at the San Diego Convention Center.
For a complete conference program please visit the AAPS website here.
Decisions, Decisions: Michael Rosenberg on Adaptive Research
Through the use of adaptive techniques, advancements in technology, and the web for global data collection, Health Decisions has made it possible for sponsors and research teams to make faster decisions. This real time decision making process is producing outstanding results by reducing the duration and overall cost of studies.
Dr. Rosenberg outlines the value of conducting adaptive trials. You can read the article in the latest issue of Bio-IT World's, eClinqua here.
You may also want to read the condensed version that appears in Octobers print issue of Bio-IT world here.
